These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 34357885)

  • 21. SARS-CoV-2 vaccine candidates in rapid development.
    Li L; Guo P; Zhang X; Yu Z; Zhang W; Sun H
    Hum Vaccin Immunother; 2021 Mar; 17(3):644-653. PubMed ID: 33121319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One and a half years into the COVID-19 pandemic - exit strategies and efficacy of SARS-CoV-2 vaccines for holistic management and achieving global control.
    Petersen E; Gökengin D; Al Balushi A; Zumla A
    Turk J Med Sci; 2021 Dec; 51(SI-1):3157-3161. PubMed ID: 34284531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.
    Khoury DS; Cromer D; Reynaldi A; Schlub TE; Wheatley AK; Juno JA; Subbarao K; Kent SJ; Triccas JA; Davenport MP
    Nat Med; 2021 Jul; 27(7):1205-1211. PubMed ID: 34002089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of micronutrient and immunomodulation effect in the vaccine era of COVID-19.
    Lai YJ; Chang HS; Yang YP; Lin TW; Lai WY; Lin YY; Chang CC
    J Chin Med Assoc; 2021 Sep; 84(9):821-826. PubMed ID: 34282078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
    Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
    J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19).
    Mirzaei R; Attar A; Papizadeh S; Jeda AS; Hosseini-Fard SR; Jamasbi E; Kazemi S; Amerkani S; Talei GR; Moradi P; Jalalifar S; Yousefimashouf R; Hossain MA; Keyvani H; Karampoor S
    Arch Virol; 2021 Jul; 166(7):1819-1840. PubMed ID: 33745067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Migraine treatment and COVID-19 vaccines: No cause for concern.
    Gelfand AA; Poland G
    Headache; 2021 Mar; 61(3):409-411. PubMed ID: 33543775
    [No Abstract]   [Full Text] [Related]  

  • 28. Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2.
    Bilal M; Iqbal HMN
    Hum Vaccin Immunother; 2020 Dec; 16(12):3034-3042. PubMed ID: 32845742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primed for global coronavirus pandemic: Emerging research and clinical outcome.
    Ahamad S; Branch S; Harrelson S; Hussain MK; Saquib M; Khan S
    Eur J Med Chem; 2021 Jan; 209():112862. PubMed ID: 33070079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative Insight into Immunopathology of SARS-CoV-2 Infection.
    Soni B; Kabra R; Singh S
    J Interferon Cytokine Res; 2021 Jul; 41(7):244-257. PubMed ID: 34280026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2: Targeted managements and vaccine development.
    Bakhiet M; Taurin S
    Cytokine Growth Factor Rev; 2021 Apr; 58():16-29. PubMed ID: 33293238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021.
    Budziar W; Gembara K; Harhala M; Szymczak A; Jędruchniewicz N; Baniecki K; Pikies A; Nahorecki A; Hoffmann A; Kardaś A; Szewczyk-Dąbrowska A; Klimek T; Kaźmierczak Z; Witkiewicz W; Barczyk K; Dąbrowska K
    PLoS One; 2022; 17(2):e0253638. PubMed ID: 35113873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Exposome and Immune Health in Times of the COVID-19 Pandemic.
    Morales JS; Valenzuela PL; Castillo-García A; Butragueño J; Jiménez-Pavón D; Carrera-Bastos P; Lucia A
    Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 vaccination hesitancy among people with chronic neurological disorders: A position paper.
    Rakusa M; Öztürk S; Moro E; Helbok R; Bassetti CL; Beghi E; Bereczki D; Bodini B; Di Liberto G; Jenkins TM; Macerollo A; Maia LF; Martinelli-Boneschi F; Pisani A; Priori A; Sauerbier A; Soffietti R; Taba P; von Oertzen TJ; Zedde M; Crean M; Burlica A; Cavallieri F; Sellner J;
    Eur J Neurol; 2022 Aug; 29(8):2163-2172. PubMed ID: 35460319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19: Structural Considerations for Virus Pathogenesis, Therapeutic Strategies and Vaccine Design in the Novel SARS-CoV-2 Variants Era.
    Volkan E
    Mol Biotechnol; 2021 Oct; 63(10):885-897. PubMed ID: 34145550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention and early treatment of the long-term physical effects of COVID-19 in adults: design of a randomised controlled trial of resistance exercise-CISCO-21.
    Morrow A; Gray SR; Bayes HK; Sykes R; McGarry E; Anderson D; Boiskin D; Burke C; Cleland JGF; Goodyear C; Ibbotson T; Lang CC; McConnachie ; Mair F; Mangion K; Patel M; Sattar N; Taggart D; Taylor R; Dawkes S; Berry C
    Trials; 2022 Aug; 23(1):660. PubMed ID: 35971155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Covid-19 challenges to immune investigations and therapies.
    Talmadge JE; Marceau F
    Int Immunopharmacol; 2021 Jun; 95():107543. PubMed ID: 33735717
    [No Abstract]   [Full Text] [Related]  

  • 38. Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates.
    Pillet S; Arunachalam PS; Andreani G; Golden N; Fontenot J; Aye PP; Röltgen K; Lehmicke G; Gobeil P; Dubé C; Trépanier S; Charland N; D'Aoust MA; Russell-Lodrigue K; Monjure C; Blair RV; Boyd SD; Bohm RP; Rappaport J; Villinger F; Landry N; Pulendran B; Ward BJ
    Cell Mol Immunol; 2022 Feb; 19(2):222-233. PubMed ID: 34983950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An update on COVID-19 and pregnancy.
    Jamieson DJ; Rasmussen SA
    Am J Obstet Gynecol; 2022 Feb; 226(2):177-186. PubMed ID: 34534497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Counseling in maternal-fetal medicine: SARS-CoV-2 infection in pregnancy.
    Di Mascio D; Buca D; Berghella V; Khalil A; Rizzo G; Odibo A; Saccone G; Galindo A; Liberati M; D'Antonio F
    Ultrasound Obstet Gynecol; 2021 May; 57(5):687-697. PubMed ID: 33724545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.